Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
513
-
Total 13F shares, excl. options
-
177,743,163
-
Shares change
-
-3,641,805
-
Total reported value, excl. options
-
$13,419,458,431
-
Value change
-
-$323,613,922
-
Put/Call ratio
-
150%
-
Number of buys
-
241
-
Number of sells
-
-256
-
Price
-
$75.51
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q1 2021
643 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q1 2021.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 513 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177,743,163 shares
of 193,539,047 outstanding shares and own 91.84% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (22,076,365 shares), PRIMECAP MANAGEMENT CO/CA/ (18,157,794 shares), VANGUARD GROUP INC (16,354,349 shares), BlackRock Inc. (13,934,157 shares), Dodge & Cox (11,854,308 shares), BAKER BROS. ADVISORS LP (7,589,294 shares), AMERIPRISE FINANCIAL INC (6,233,335 shares), Clearbridge Investments, LLC (5,003,970 shares), JANUS HENDERSON GROUP PLC (4,993,655 shares), and STATE STREET CORP (4,674,402 shares).
This table shows the top 513 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.